IL10 and acute respiratory distress syndrome: While no such therapy has reached clinical trials yet, preclinical research is examining possibilities like mRNA-encoded IL-10 (an anti-inflammatory cytokine) to dampen cytokine storms in ARDS, or soluble ACE2 to act as a decoy for SARS-CoV-2.